INZY - Inozyme Pharma, Inc. Stock Price, Fair Value and News

$2.99+0.18 (+6.41%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

INZY Price Action

Last 7 days

-1.3%

Last 30 days

7.2%

Last 90 days

-47.8%

Trailing 12 Months

-26.5%

INZY RSI Chart

INZY Valuation

Market Cap

192.1M

Price/Earnings (Trailing)

-1.99

Price/Free Cashflow

-2.1

INZY Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

INZY Fundamentals

INZY Earnings

Earnings (TTM)

-96.5M

Earnings Growth (Yr)

-47.67%

Earnings Growth (Qtr)

9.11%

INZY Profitability

Return on Equity

-116.56%

Return on Assets

-67.31%

Free Cashflow Yield

-47.56%

INZY Investor Care

Shares Dilution (1Y)

4.01%

Diluted EPS (TTM)

-1.55

Revenue & Growth

About Inozyme Pharma, Inc.

Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases in the United States. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein, which is in Phase 1/2 clinical trials for the treatment of ENPP1 and ABCC6 deficiency, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

CEO	Dr. Douglas A. Treco Ph.D.
WEBSITE	inozyme.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	56

Inozyme Pharma, Inc. Frequently Asked Questions

What is the ticker symbol for Inozyme Pharma, Inc.? What does INZY stand for in stocks?

INZY is the stock ticker symbol of Inozyme Pharma, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Inozyme Pharma, Inc. (INZY)?

As of Fri Dec 20 2024, market cap of Inozyme Pharma, Inc. is 192.08 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INZY stock?

You can check INZY's fair value in chart for subscribers.

Is Inozyme Pharma, Inc. a good stock to buy?

The fair value guage provides a quick view whether INZY is over valued or under valued. Whether Inozyme Pharma, Inc. is cheap or expensive depends on the assumptions which impact Inozyme Pharma, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INZY.